| Recruitment status | Main results already published |
| Unique ID issued by UMIN | UMIN000005061 |
| Receipt No. | R000006004 |
| Official scientific title of the study | A phase I study of stereotactic body radiotherapy with real-time tumor tracking using CyberKnife and Monte Carlo algorithm for lung tumors. |
| Date of disclosure of the study information | 2011/02/18 |
| Last modified on | 2018/08/17 (Ver. 11) |
| Basic information | ||
| Official scientific title of the study | A phase I study of stereotactic body radiotherapy with real-time tumor tracking using CyberKnife and Monte Carlo algorithm for lung tumors. | |
| Title of the study (Brief title) | A phase I study of stereotactic body radiotherapy with real-time tumor tracking using CyberKnife and Monte Carlo algorithm for lung tumors. | |
| Region |
|
|
| Condition | |||
| Condition | lung tumor | ||
| Classification by specialty |
|
||
| Classification by malignancy | Malignancy | ||
| Genomic information | NO | ||
| Objectives | |
| Narrative objectives1 | To evaluate the efficacy and safety of SBRT with real-time tumor tracking using CyberKnife and Monte Carlo argorythm for lung tumors. (phase I study) |
| Basic objectives2 | Safety |
| Basic objectives -Others | |
| Trial characteristics_1 | Exploratory |
| Trial characteristics_2 | |
| Developmental phase | Phase I |
| Assessment | |
| Primary outcomes | incidence of Grade 3 or higher radiation pneumonitis within 180 days after stereotactic body radiotherapy |
| Key secondary outcomes | Overall survival, Progression-free survival, local progression-free survival, 3-year survival, 3 year local progression free survival, Event-free survival, 3 year local control rate, pattern of progression, Grade 2 or higher radiation pneumonitis, adverse event, severe adverse event |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Single arm |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Uncontrolled |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 1 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | Stereotactic body radiotherapy using real-time tumor tracking with 45 or 50 or 55 Gy delivered in 4 fractions, once a day, twice a week. | |
| Interventions/Control_2 | ||
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1.Histologically or transbronchoscopic cytologically confirmed Primary or metastatic lung cancer diagnosed by images
2.cT1aN0M0,cT1bN0M0,cT2aN0M0(UICC7th) or lung oligometastasis within 5 cm diagnosed by images within 28 days 3.Dose constraints of the organs at risk seem to be limited within range 4.no previous radiotherapy around the lesion 5.20 years old or higher 6.ECOG-PS=0-2 7.Respiratory function (<=28 days) (1)PaO2>=60 torr (2)FEV1.0>=700 ml 8.Only tracking irradiation 9.Written informed consent |
|||
| Key exclusion criteria | 1.active infection needed therapy
2.fever of 38.0 degrees centigrade or higher 3.pregnancy 4.psychiatric disorder 5.steroid administration 6.Patients who are considered to be inappropriate for this study by physicians |
|||
| Target sample size | 35 | |||
| Research contact person | |
| Name of lead principal investigator | Yuta Shibamoto |
| Organization | Nagoya City University Graduate School of Medical Sciences |
| Division name | Radiology |
| Address | 1 Kawasumi, Mizuho-cho, Mizuho-ku, Nagoya, Aichi, 467-8601, Japan |
| TEL | 052-853-8276 |
| yshiba@med.nagoya-cu.ac.jp | |
| Public contact | |
| Name of contact person | Hiromitsu Iwata |
| Organization | Nagoya City West Medical Center |
| Division name | Nagoya Proton Therapy Center |
| Address | 1-1-1, Hirate-cho, Kita-ku, Nagoya |
| TEL | 052-991-8588 |
| Homepage URL | |
| cyber@syck.jp | |
| Sponsor | |
| Institute | Department of Radiology, Nagoya City University Graduate School of Medical Sciences |
| Institute | |
| Department | |
| Funding Source | |
| Organization | none |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | Shinryoku neurosurgical clinic, Yokohama CyberKnife Center |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 新緑脳神経外科横浜サイバーナイフセンター(神奈川県) |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Main results already published | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | http://www.syck.jp/medical_care/cyberknife5.html |
| Publication of results | Published |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000006004 |